Ameliorative effect of betanin on monosodium glutamate-induced mouse ADHD and modulation of Nrf2 and TLR4/NFκB/p53 interplay

Abstract Background Attention-deficit hyperactivity disorder (ADHD) is a state of poor attention and hyperactivity. Neuroinflammation and oxidative stress are complicated in the pathology of ADHD. Betanin is a potent water-soluble nitrogen-containing antioxidant and anti-inflammatory molecule not tested before in ADHD models. The current study aimed to test the ability of betanin to mitigate ADHD in mice in terms of cognitive and motor dysfunction, in addition to brain histopathology, neurotransmitter levels and inflammatory protein levels; the molecular study was supported by a bioinformatic investigation. Male albino mice were allotted to three experimental groups: (i): normal, (ii): ADHD group, (iii) ADHD + betanin 50 mg/kg. We induced ADHD by including monosodium glutamate (SGLU) in the diet for 8 weeks. Cognitive and motor dysfunction were evaluated using the open field test (OF-T) for locomotor alterations, the marble burying test (MB-T) for attention and compulsive behavior, and the rope crawling test. Results The ADHD control group (fed with SGLU) showed increased activities in the OF-T and high compulsive behavior in the MB-T. Further, high brain glutamate and low dopamine levels were observed in the ADHD control group along with high levels of malondialdehyde and inflammatory parameters such as toll-like receptors (TLRs), tumor necrosis factor-α (TNF-α), nuclear transcription factor-κB (NFκB), interleukin-1β (IL-1β), and IL6. Conversely, brain Nrf2 and total antioxidants were reduced in the ADHD group. Microscopic investigation showed pathological alterations in the brain. Western blot analysis and immunostaining showed greater levels of p-53 in the ADHD group versus the normal group. Conclusions Orally administered betanin improved most neurobehavioral, biochemical, and histopathological findings in the ADHD model in mice. Hence, betanin can be considered for further investigation as a useful food component in children for mitigating ADHD symptoms. Graphical abstract

Authors

Institutions

Publication Details

Journal
Future Journal of Pharmaceutical Sciences
Published
2025-09-18
DOI
https://doi.org/10.1186/s43094-025-00844-0
Citations
2
Primary Topic
Attention Deficit Hyperactivity Disorder
Type
article
Field-Weighted Citation Impact
2.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ameliorative effect of betanin on monosodium glutamate-induced mouse ADHD and modulation of Nrf2 and TLR4/NFκB/p53 interplay

Sawsan A. Zaitone, Noha M. Abd El‐Fadeal, Nermine Nosseir, Shaimaa A. Shehata et al.
2 citations
Future Journal of Pharmaceutical Sciences
Attention Deficit Hyperactivity Disorder
2.94
article

Ameliorative effect of betanin on monosodium glutamate-induced mouse ADHD and modulation of Nrf2 and TLR4/NFκB/p53 interplay

Sawsan A. Zaitone, Noha M. Abd El‐Fadeal, Nermine Nosseir, Shaimaa A. Shehata, Abdulrahman Nasr, Hatem I. Mokhtar, Heba K. Badawy, Eman Wahsh, Mohamed A. Zayed, Ahmed Al‐Emam
article en
2 citations

Abstract

Abstract Background Attention-deficit hyperactivity disorder (ADHD) is a state of poor attention and hyperactivity. Neuroinflammation and oxidative stress are complicated in the pathology of ADHD. Betanin is a potent water-soluble nitrogen-containing antioxidant and anti-inflammatory molecule not tested before in ADHD models. The current study aimed to test the ability of betanin to mitigate ADHD in mice in terms of cognitive and motor dysfunction, in addition to brain histopathology, neurotransmitter levels and inflammatory protein levels; the molecular study was supported by a bioinformatic investigation. Male albino mice were allotted to three experimental groups: (i): normal, (ii): ADHD group, (iii) ADHD + betanin 50 mg/kg. We induced ADHD by including monosodium glutamate (SGLU) in the diet for 8 weeks. Cognitive and motor dysfunction were evaluated using the open field test (OF-T) for locomotor alterations, the marble burying test (MB-T) for attention and compulsive behavior, and the rope crawling test. Results The ADHD control group (fed with SGLU) showed increased activities in the OF-T and high compulsive behavior in the MB-T. Further, high brain glutamate and low dopamine levels were observed in the ADHD control group along with high levels of malondialdehyde and inflammatory parameters such as toll-like receptors (TLRs), tumor necrosis factor-α (TNF-α), nuclear transcription factor-κB (NFκB), interleukin-1β (IL-1β), and IL6. Conversely, brain Nrf2 and total antioxidants were reduced in the ADHD group. Microscopic investigation showed pathological alterations in the brain. Western blot analysis and immunostaining showed greater levels of p-53 in the ADHD group versus the normal group. Conclusions Orally administered betanin improved most neurobehavioral, biochemical, and histopathological findings in the ADHD model in mice. Hence, betanin can be considered for further investigation as a useful food component in children for mitigating ADHD symptoms. Graphical abstract

Future Journal of Pharmaceutical SciencesVol. 11(1)
Suez Canal University (EG), Sinai University (EG), Mansoura University (EG), Gulf Medical University (AE), King Abdulaziz University (SA), Ibn Sina National College for Medical Studies (SA), Arish University (EG), Menoufia University (EG), University of Tabuk (SA), King Khalid University (SA)
Openalex Percentile: Top 8%
Attention Deficit Hyperactivity Disorder
2.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.